Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of 1% and 3% Topical MIinocycline Gel (HY01) in Patients With Papulopustular Rosacea

NCT03263273 is registered in ClinicalTrials.gov with Hovione Scientia Limited as lead sponsor.

NCT NCT03263273
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03263273 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of 1% and 3% Topical MIinocycline Gel (HY01) in Patients With Papulopustular Rosacea
Lead sponsor
Hovione Scientia Limited
Phase
Phase 2
Overall status
Completed
Start date
October 30, 2017
Completion date
July 1, 2019
Enrollment
270 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

papulopustular rosacea, rosacea